Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen L Fitzsimons

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
BMC Biotechnology|March 24, 2016
Towards next generation maggot debridement therapy: transgenic Lucilia sericata larvae that produce and secrete a human growth factorRebecca J Linger, Esther J Belikoff, Ying Yan, et al.
Science (New York, N.Y.)|October 12, 2002
Subthalamic GAD gene therapy in a Parkinson's disease rat modelJia Luo, Michael G Kaplitt, Helen L Fitzsimons, et al.
Molecular Microbiology|November 25, 2016
SymB and SymC, two membrane associated proteins, are required for Epichloë festucae hyphal cell-cell fusion and maintenance of a mutualistic interaction with Lolium perenneKimberly A Green, Yvonne Becker, Aiko Tanaka, et al.
Lancet (London, England)|June 26, 2007
Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trialMichael G Kaplitt, Andrew Feigin, Chengke Tang, et al.
Nature Medicine|August 20, 2003
Glucagon-like peptide-1 receptor is involved in learning and neuroprotectionMatthew J During, Lei Cao, David S Zuzga, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
BMC Biotechnology|March 24, 2016
Towards next generation maggot debridement therapy: transgenic Lucilia sericata larvae that produce and secrete a human growth factorRebecca J Linger, Esther J Belikoff, Ying Yan, et al.
Science (New York, N.Y.)|October 12, 2002
Subthalamic GAD gene therapy in a Parkinson's disease rat modelJia Luo, Michael G Kaplitt, Helen L Fitzsimons, et al.
Molecular Microbiology|November 25, 2016
SymB and SymC, two membrane associated proteins, are required for Epichloë festucae hyphal cell-cell fusion and maintenance of a mutualistic interaction with Lolium perenneKimberly A Green, Yvonne Becker, Aiko Tanaka, et al.
Lancet (London, England)|June 26, 2007
Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trialMichael G Kaplitt, Andrew Feigin, Chengke Tang, et al.
Nature Medicine|August 20, 2003
Glucagon-like peptide-1 receptor is involved in learning and neuroprotectionMatthew J During, Lei Cao, David S Zuzga, et al.
Pageof 3